Literature DB >> 23105369

Kinetic analysis of LDL oxidation in IHD and IHD risk subjects in Indian population.

Yashika Gupta1, V Mallika, D K Srivastava.   

Abstract

High plasma concentration of low-density lipoprotein (LDL) is associated with increased risk of atherosclerosis. Modified forms of LDL, especially oxidized LDL play a major role in its pathogenesis. This article gives detailed insight into the kinetics ofin vitro LDL oxidation by copper at different concentrations in normal and high-risk group subjects. Basal level of oxidatively modified LDL was significantly higher in ischaemic heart disease (IHD) and IHD hyperlipidemic subjects compared to normolipidemic and, hyperlipidemic control subjects, respectively. Derivatization of amino groups of apo-lipoprotein as monitored by estimating free amino groups concentration, was significantly higher in high-risk group and established IHD cases. Kinetics of oxidation was studied with two different concentrations of CuSO(4) (2.5 mM and 7.5 mM). thiobarbituric acid reactive substances (TBARS) level increases with time, and up to 95% oxidation was observed in 8 hr. About 60-65% less free amino groups were observed in native-LDL isolated from IHD patients compared to normal subjects. Study also showed an increase in two oxidative products studied, 20α-OH-cholesterol and 4-cholesten-3-one with oxidation time accompanied by corresponding decrease in LDL cholesterol. Increase in oxidative species was more evident in high-risk group and IHD patient. Basal level of oxidatively modified LDL measured in terms of TBARS was significantly higher in present study, strongly support that the extent of LDL oxidation monitored as TBARS and FAG level in circulating-LDL could be used as risk marker for high risk group.

Entities:  

Keywords:  Cholesterol; FAG; HPLC; Kinetics; LDL; ox-LDL

Year:  2003        PMID: 23105369      PMCID: PMC3453728          DOI: 10.1007/BF02867663

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  23 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Oxidation of membrane cholesterol alters active and passive transsarcolemmal calcium movement.

Authors:  M J Kutryk; T G Maddaford; B Ramjiawan; G N Pierce
Journal:  Circ Res       Date:  1991-01       Impact factor: 17.367

Review 3.  Lipoproteins and atherosclerosis. A look back and a look ahead.

Authors:  D Steinberg
Journal:  Arteriosclerosis       Date:  1983 Jul-Aug

4.  Induction of T-cell activation by oxidized low density lipoprotein.

Authors:  J Frostegård; R Wu; R Giscombe; G Holm; A K Lefvert; J Nilsson
Journal:  Arterioscler Thromb       Date:  1992-04

5.  Capillary GC quantification of cholesterol oxidation products in plasma lipoproteins of fasted humans.

Authors:  P B Addis; H A Emanuel; S D Bergmann; J H Zavoral
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

Review 6.  The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide.

Authors:  A Carr; B Frei
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

Review 7.  Myeloperoxidase-generated oxidants and atherosclerosis.

Authors:  E A Podrez; H M Abu-Soud; S L Hazen
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

8.  Oxidative status of lipoproteins in coronary disease patients.

Authors:  K Z Liu; T E Cuddy; G N Pierce
Journal:  Am Heart J       Date:  1992-02       Impact factor: 4.749

9.  Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease.

Authors:  H C Chiu; J R Jeng; S M Shieh
Journal:  Biochim Biophys Acta       Date:  1994-01-11

10.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

Authors:  M Burstein; H R Scholnick; R Morfin
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.